The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.

Three-day event brought together leading scientists, researchers, and young scholars from India and abroad, fostering ...

The three-day event, held at the University of Hyderabad, brought together leading researchers from India and abroad to ...

As we approach another year of groundbreaking research in cancer care and significant treatment innovations, various companies are taking the ...

The College of Veterinary Medicine is hosting a public health conference in the Stewart Center about antimicrobial resistance ...

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

James made a notable change in their assessment of Third Harmonic (NASDAQ:HLIT) Bio (NASDAQ:THRD), downgrading the biotechnology company's stock rating from Outperform to Market Perform. According to ...

The Plant and Animal Genomics conference recently held in San Diego showcased the ways that rapidly advancing technologies can be used in the crop and livestock sectors ...

By sharing the stories of EDI champions in science, we hope to shed light on both the importance of diversity and the ...

Results from GALILEO-1, a first in human clinical trial of FLT201 AAV-gene therapy in adult patients with Gaucher disease type 1 (Poster #318) Session: Poster Session III Date & Time: Thursday, ...